Diabetes, Weight Change, and Pancreatic Cancer Risk-Reference-Cited by-同舟云学术

Diabetes, Weight Change, and Pancreatic Cancer Risk

Published:2020-10-08 Issue:10 Volume:6 Page:e202948
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Yuan Chen¹,Babic Ana¹,Khalaf Natalia²³,Nowak Jonathan A.⁴⁵,Brais Lauren K.¹,Rubinson Douglas A.¹,Ng Kimmie¹,Aguirre Andrew J.¹,Pandharipande Pari V.⁶,Fuchs Charles S.⁷,Giovannucci Edward L.⁸⁹¹⁰,Stampfer Meir J.⁸⁹¹⁰,Rosenthal Michael H.¹,Sander Chris¹¹¹²,Kraft Peter⁸¹³,Wolpin Brian M.¹

Affiliation:

1. Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts

2. Department of Internal Medicine, Baylor College of Medicine, Houston, Texas

3. Gastroenterology and Hepatology, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas

4. Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

5. Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts

6. Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

7. Yale Cancer Center, Smilow Cancer Hospital, New Haven, Connecticut

8. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

9. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

10. Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

11. Department of Cell Biology, Harvard Medical School, Boston, Massachusetts

12. cBio Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts

13. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2769304/jamaoncology_yuan_2020_oi_200040_1619718195.24347.pdf

Reference37 articles.

1. Cancer statistics, 2020.;Siegel;CA Cancer J Clin,2020

2. Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance.;Canto;Gastroenterology,2018

3. Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European expert centers.;Vasen;J Clin Oncol,2016

4. Pancreatic cancer.;Kamisawa;Lancet,2016

5. Screening for pancreatic cancer: US Preventive Services Task Force reaffirmation recommendation statement.;Owens;JAMA,2019

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study;HPB;2024-08

2. Findings on Age at Onset of Cancer in Diabetic and Non-diabetic Populations;Cureus;2024-07-30

3. Overcoming underestimation of the association of excess weight with pancreatic cancer due to prediagnostic weight loss: Umbrella review of systematic reviews, meta‐analyses, and pooled‐analyses;Obesity Reviews;2024-07-25

4. Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990–2019 and projections up to 2040;Frontiers in Endocrinology;2024-07-05

5. Combined ultrasound endoscopy-guided fine-needle aspiration with DNA methylation of SHOX2 and RASSF1A genes to enhance the auxiliary diagnostic precision of pancreatic cancer;Heliyon;2024-07